Proof of Usefulness Report

Freenome

Analysis completed on 1/22/2026

+671
Proof of Usefulness Score
Category Standard

Freenome is a verified late-stage biotechnology unicorn with over $1.35 billion in funding and strategic partnerships with Roche and Exact Sciences. While the project has immense real-world utility and verified traction (FDA filings, clinical trials), the submission itself is of low quality, containing hallucinated traction claims ('most people have used my product') and generic descriptions. The score reflects the high objective value of the company, significantly penalized for the submission's inaccuracy and lack of effort.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+237.5
Audience Reach Impact+130.0
Technical Innovation+135.0
Evidence Of Traction+118.8
Market Timing Relevance+95.0
Functional Completeness+5.0
Subtotal+721.3
Usefulness Multiplierx0.93
Final Score+671

Project Details

Project URL
freenome.com
Description
Freenome is on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent diseases. If you crave challenges, understudied problems, and the chance to see your work impact the millions of lives touched by cancer, there’s no better place to be.\nWe are committed to our core values of empathy, integrity, and trust enable us to push through challenges, learn from mistakes, and support one another to reach our fullest potential. \n\nBy applying advanced ML techniques to recent breakthroughs in genomic science, Freenome is developing simple blood tests to detect early-stage cancer and make treatments more effective. The company has raised $238M from investors such as RA Capital, Polaris Partners, Perceptive Advisors, a16z, funds/accounts advised by T. Rowe Price Associates, Inc., GV (fka Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society’s BrightEdge Ventures, Data Collective Venture Capital, \u0026 Verily Life Sciences.

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline